FDA NDC Directory · JSON-LD · Markdown

ABRAXANE

NDC 68817-134 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Generic namePaclitaxel
Labeler / ManufacturerAbraxis BioScience, LLC
Marketing categoryNew Drug Application (innovator) · App NDA021660
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsPACLITAXEL (100 mg/20mL)
Marketing started20050210
Package count1

External sources

Source: openFDA. Public-domain (CC0).